As U.S. trade tensions rise, the biotechnology sector faces a critical challenge against China's growing influence. Historically, the U.S. led in biotechnology, just as it once did in semiconductors, but this leadership is being threatened. American authors, connected with the NSCEB, report that China has invested heavily to catch up in biotech and warns that without effective collaboration between the U.S. government and its biotech industry, the country may lose its competitive edge in vital areas of medicine and defense. Immediate actions are necessary to limit foreign investment and promote domestic funding.
In the biotech sector, as in semiconductors, American innovation is at risk of being overwhelmed by Chinese advancements unless decisive action is taken.
We must collaborate between industry and government if we are to regain our position in biotech and prevent a repeat of the semiconductor situation.
Collection
[
|
...
]